TipRanks on MSN
Silver Wolf Exploration Announces CAD $1.5 Million Private Placement to Fund Mexican Drilling Program
Silver Wolf Exploration ( (TSE:SWLF) ) has provided an update. Silver Wolf Exploration Ltd. announced a non-brokered private placement offering of up to 10,000,000 units at C$0.15 per unit, aiming to ...
Sienna Resources Inc. (TSXV: SIEN) (FSE: A418KR), (the “Company” or “Sienna”) is pleased to announce that, further to its news ...
An update from Sienna Resources ( ($TSE:SIEN) ) is now available. Sienna Resources Inc. has successfully closed the first tranche of its private ...
Proceeds to fund expanded exploration programs at Escacena and Cármenes Projects in Spain, including airborne geophysical survey over newly awarded Escacena South mineral rights VANCOUVER, BC, Oct. 6, ...
(RTTNews) - XORTX Therapeutics Inc. (XRTX), a late-stage clinical pharmaceutical firm focused on therapies for progressive kidney disease and gout, has launched a non-brokered private placement to ...
The offering was led by an initial investment from a preeminent asset manager alongside several new and existing institutional investors Company’s cash position expected to be approximately $600 ...
Grail CEO Bob Ragusa: "If you look at 1 million people, that means with the Galleri test, you're looking at 5,000 false ...
Gold Port Corporation (CSE: GPO) (OTCQB: GPOTF) ("Gold Port" or the "Company") is pleased to announce a non-brokered ...
Funding expected to provide cash runway into 2026 98% of investment in private placement from Pre-IPO and/or IPO investors Data update from OST-HER2 Phase 2b clinical trial in recurrent, resected ...
Highlights: Formation has closed $8,262,389.48 in gross proceeds, fully funding its planned 20,000 metre total multi-phase ...
SAN FRANCISCO, October 06, 2025--(BUSINESS WIRE)--IMPACT Community Capital LLC ("IMPACT") completed a third Private Placement Participate Certification ("PC") Swap with Freddie Mac, swapping 57 ...
WILMINGTON, Del., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results